DUBLIN, Ireland--(BUSINESS WIRE)--Jul. 22, 2014--
Covidien
plc (NYSE: COV) today announced that Bryan Hanson, who currently
serves as group president, Medical Devices & U.S., will be elevated to
the newly created position of group president, Covidien, effective Oct.
1. In this role, Hanson will have global responsibility for all Covidien
business segments.
Hanson has overseen the company’s Surgical Solutions, Vascular Therapies
and Respiratory & Monitoring Solutions business units, as well as its
Health Systems organization, since October 2013. He recently assumed
oversight of the company’s Emerging Markets business and will add
responsibility for the company’s Developed Markets and Medical Supplies
businesses when his appointment becomes effective.
“Bryan is a proven global leader who has deep experience in our industry
and will help advance our company in delivering new value, products and
capabilities to our customers and patients around the world,” said José
E. Almeida, chairman, president and CEO, Covidien. “This new
organizational structure addresses important business requirements while
positioning Covidien for the future.”
Hanson joined Covidien in 1992 and has held positions of increasing
responsibility in sales, marketing and general management. Prior to
being appointed group president, Medical Devices & U.S., Hanson served
as group president, Surgical Solutions, and president, Energy-based
Devices. Hanson holds a Bachelor of Science degree in Finance from
Florida State University.
About Covidien
Covidien is a global health care leader that understands the challenges
faced by providers and their patients and works to address them with
innovative medical technology solutions and patient care products.
Inspired by patients and caregivers, Covidien’s team of dedicated
professionals is privileged to help save and improve lives around the
world. With more than 38,000 employees, Covidien operates in 150-plus
countries and had 2013 revenue of $10.2 billion. To learn more about our
business visit www.covidien.com
or connect with us on Twitter.
Source: Covidien plc
Covidien
Peter Lucht, 508-452-4168
Vice President
External
Communications
peter.lucht@covidien.com
or
Lisa
Clemence, 508-452-4375
Director
Corporate Communications
lisa.clemence@covidien.com
or
Coleman
Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Todd
Carpenter, 508-452-4363
Senior Director
Investor Relations
todd.carpenter@covidien.com
View printer-friendly version
